//./ActionParams/@language -> $page_language ->

Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.
10,752.20-61.25
Stock Analysis, IPO, Mutual Funds, Bonds & More
ENG
  • ENG - English
  • HIN - हिन्दी
  • GUJ - ગુજરાતી
  • MAR - मराठी
  • BEN - বাংলা 
  • KAN - ಕನ್ನಡ 
  • ORI - ଓଡିଆ
  • TEL - తెలుగు
  • TAM - தமிழ்

Dr. Reddy's Laboratories Ltd.

OPEN TRADING A/C
  • NSE
  • BSE
Last Updated on 10 Jul, 2020, 11:17 AM IST
3919.95

Today's Change

23.35 (0.60%)

Volume
AVERAGE VOLUME
5-Day
10-Day
30-Day

472,654

Open

3899.70

Prev. Close

3896.60

Day's Trend

Low
3883.20
High
3957.00
  • Bid
  • Mkt Cap (₹ Cr.)
  • P/E (x)
  • P/B (x)
  • Div_ Yield (%)
  • BETA
    BETA
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
  • Offer
  • Face Value (₹)5.00
  • EPS-TTM (Rs.)121.92
  • BV/share (₹)938.56
  • 52Wk L/H2351.20/ 4190.00
  • Avg. Daily Volatility %
    Avg. Daily Volatility %
    1 Month
    3-Months
    6-Months
    1 Year
    3-Years
InsightsCandle Pattern| Events| Recos| Updates| News

Dr. Reddy's Laboratories Ltd Stock Price F & O Quotes

Buy Dr Reddy's Labs, target price Rs 4,426: Nomura| Recos
Buy
Dr. Reddy's Laboratories Ltd.Statement Of Investor Complaints For The Quarter Ended June 2020| Announcement
Dr. Reddy's Laboratories Ltd.Newspaper Advertisement| Announcement
Dr. Reddy's Laboratories Ltd.Reg. 34 (1) Annual Report| Announcement
Dr. Reddy's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Dr. Reddy's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
Dr. Reddy's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)| Announcement
Dr. Reddy's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Dr. Reddy's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Dr. Reddy's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
Dr. Reddy's Laboratories Ltd.Intimation Of Date Of Annual General Meeting| Announcement
Dr. Reddy's Laboratories Ltd.Intimation Of Book Closure| Announcement
Dr. Reddy's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS| Announcement
Dr. Reddy's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Dr. Reddy's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Dr. Reddy's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Dr. Reddy's Laboratories Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
Dr. Reddy's Laboratories Ltd.Disclosure Of Related Party Transactions For The Half Year Ended March 31, 2020.| Announcement
Dr. Reddy's Laboratories Ltd.Intimation| Announcement
Dr. Reddy's Laboratories Ltd.Intimation| Announcement
Dr. Reddy's Laboratories Ltd.Compliances-Reg.24(A)-Annual Secretarial Compliance| Announcement
Analyst Calls: RBL Bank, Dr Reddy's Laboratories| News

Dr. Reddy's Laboratories Ltd. Share Price Updates

Dr. Reddy's Laboratories Ltd. share price up by 1.25% from its previous close of Rs 3896.60. Dr. Reddy's Laboratories Ltd. stock last traded price is 3945.15
Dr. Reddy's Laboratories Ltd. Share Price
Value
Today/Current/Last
3945.15
Previous Day
3896.60
What's your view on Dr. Reddy's Laboratories for the week?
Bearish
Bullish
View community Outlook >>

Be the first one to post on Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories Ltd.
Quarterly Results

Figures in Rs. Cr
Mar 2020 
% Chg (Quarterly)
% Chg (Yearly)
Peer Range
Trend
Last 12 Quarters Trend
Sales
4,431.80
1.09
10.34
0.00
8184.94
Other Operating Income
17.10
28.57
31.54
0.00
106.91
Operating Profit
949.20
NA
15.91
-25.07
2273.65
Other Income
73.60
9.36
-11.64
-0.76
208.60
EBITDA
1,022.80
NA
13.37
-25.07
2273.65
Interest
23.00
51.32
-6.12
0.00
107.38
Depreciation
274.10
-4.46
-4.56
0.01
575.38
Tax
-44.90
NA
NA
-143.86
228.52
Net Profit
781.10
NA
71.52
-203.93
849.83
EPS (₹)
47.03
NA
71.58
-22.76
47.03

Dr. Reddy's Laboratories Ltd Share Price

Vs Peers
Companies
LTP
Intraday
1W %
1M %
1 QTR %
1 YR %
3 YR %
5 Yr %
Trend -
D|M|Y
3938.95
1.09
0.45
-4.22
8.76
52.40
44.48
5.02
873.25
0.72
-2.98
-5.94
10.52
14.88
-23.99
-53.33
496.00
2.92
4.02
-0.63
9.14
26.47
-12.01
-44.98
359.55
0.98
-1.86
-2.61
2.41
57.49
-30.80
-5.02
645.00
0.93
0.97
0.32
11.28
18.36
17.44
-0.46
2431.25
0.34
3.42
2.21
-10.25
36.89
32.42
0.00
821.85
1.10
5.66
3.12
78.59
37.64
15.85
13.14
2403.25
1.69
0.34
-2.26
-5.77
55.11
84.74
80.87
2220.10
2.01
1.35
-7.29
-3.93
36.75
201.89
136.63
1640.55
-0.39
-1.33
2.73
2.36
72.42
246.66
138.31
419.20
3.26
5.97
7.50
25.60
69.99
160.32
438.96
Top Loser for the period amongst the peers
Top Gainer for the period amongst the peers

Dr. Reddy's Laboratories Ltd Risk Return Comparison

with peersNew

Dr. Reddy's Laboratories Ltd
Financial Comparison

with peers
Management Efficiency
Dr. Reddy's Laboratories Ltd 
peer Average
Peer Range
Trend
Return on Equity (%)
12.98
7.47
-97.73
37.52
Return on Assets (%)
9.86
5.40
-34.68
37.98
Return on capital Employed (%)
9.96
10.49
-13.51
29.19
Fixed Assets Turnover (x)
1.01
0.91
0.00
2.51
Profitability and Growth
Gross Profit Margin (%)
7.46
10.48
-29.80
43.32
Operating Profit Margin(%)
14.10
16.37
-10.13
46.18
Net Profit margin (%)
11.56
5.09
-98.56
38.01
Financial Strength
Liquidity
Quick Ratio (x)
1.27
2.17
0.59
37.52
Current Ratio (x)
2.08
2.99
0.67
37.52
Cash ratio (x)
0.04
0.27
0.00
2.43
Solvency
Debt Equity Ratio (x)
0.01
0.21
0.00
3.08
Coverage Ratios
Cash flows to long term debt (x)
0.57
2.79
0.00
24.88
Better performer than its peers on this ratioAverage performer than its peers on this ratioUnderperformer than its peers on this ratio

Dr. Reddy's Laboratories Ltd Share Holding as on 31-03-2020

CategoryNo. of sharesPercentage
Promoters44,458,52826.75
ForeignInstitutions50,098,32630.15
NBanksMutualFunds14,539,1668.75
Others35,434,74621.32
GeneralPublic11,935,3667.18
FinancialInstitutions9,310,0005.60
GDR395,9500.24

MF Ownership Of Dr. Reddy's Laboratories Ltd. Shares

Fund Name
Category
No. of shares
% Change in Shares (MOM basis)
% of AUM
Amount Invested (in ₹ Cr)
Axis Bluechip Direct-G
Portfolio as on 30-06-2020
Equity: Large Cap
965602
30.49%
2.62%
380.93
SBI Equity Hybrid Direct-G
Portfolio as on 30-06-2020
Hybrid: Aggressive Hybrid
700000
0.00%
0.91%
276.15
Axis Long Term Equity Direct-G
Portfolio as on 30-06-2020
Equity: ELSS
688981
16.68%
1.34%
271.80
Kotak Equity Arbitrage Direct-G
Portfolio as on 30-06-2020
Hybrid: Arbitrage
522750
24.09%
1.3%
206.22
HDFC Arbitrage Direct-G
Portfolio as on 30-06-2020
Hybrid: Arbitrage
343250
10.90%
2.29%
135.41

Liquid, Ultra Short Term funds and FMPs are not taken into account.

More Schemes »

About Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories Ltd., incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 65557.38 Crore) operating in Pharmaceuticals sector.

Dr. Reddy's Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 10466.70 Crore to Sales Value (98.50 % of Total Sales), Licence Fees which contributed Rs 55.90 Crore to Sales Value (0.52 % of Total Sales), Service Income which contributed Rs 50.30 Crore to Sales Value (0.47 % of Total Sales), Spent Chemicals which contributed Rs 35.60 Crore to Sales Value (0.33 % of Total Sales), Scrap which contributed Rs 16.10 Crore to Sales Value (0.15 % of Total Sales) and Other Operating Revenue which contributed Rs .90 Crore to Sales Value (0.00 % of Total Sales)for the year ending 31-Mar-2019.

For the quarter ended 31-03-2020, the company has reported a Consolidated sales of Rs 4431.80 Crore, up 1.09 % from last quarter Sales of Rs 4383.80 Crore and up 10.34 % from last year same quarter Sales of Rs 4016.60 Crore Company has reported net profit after tax of Rs 770.60 Crore in latest quarter.

The company’s top management includes Dr.Bruce L A Carter, Ms.Kalpana Morparia, Mr.Sridar Iyengar, Mr.Prasad R Menon, Mr.Leo Puri, Mr.K Satish Reddy, Mr.G V Prasad, Mr.Bharat N Doshi, Mr.Allan Oberman, Ms.Shikha Sharma. Company has S R Batliboi & Associates LLP as its auditors As on 31-03-2020, the company has a total of 166,172,082 shares outstanding.

Close X
WatchlistPortfolio

Current Price>: 2389.88

Set Alert

Loading
Please wait...

Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.
BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
By using this site, you agree to the Terms of Service and Privacy Policy.

Other useful Links


Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service

Loadingdata
More on:
Prices| Financials | Company Info | Reports | News | Competitors